A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 6 (3) , 202-209
- https://doi.org/10.1016/s1201-9712(02)90112-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy childrenInfection, 1998
- Measles Elimination in the AmericasJAMA, 1996
- Complications of mumps vaccinesReviews in Medical Virology, 1995
- A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccinesThe Lancet, 1995
- The Elimination of Indigenous Measles, Mumps, and Rubella from Finland by a 12-Year, Two-Dose Vaccination ProgramNew England Journal of Medicine, 1994
- The Jeryl Lynn Vaccine Strain of Mumps Virus is a Mixture of Two Distinct IsolatesJournal of General Virology, 1993
- Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK childrenThe Lancet, 1993
- Variations of nucleotide sequences and transcription of the SH gene among mumps virus strainsVirology, 1991
- Effect of monovalent measles and trivalent measles-mumps-rubella vaccines at various ages and concurrent administration with hepatitis B vaccineThe Pediatric Infectious Disease Journal, 1990
- Trivalent Combined Measles-Mumps-Rubella VaccineJAMA, 1971